Smallpox vaccination may confer cross-protection to mpox. We evaluated vaccinia virus antibodies in 162 persons ≥50 years of age in Spain; 68.5% had detectable antibodies. Highest coverage (78%) was among persons 71-80 years of age. Low antibody levels in 31.5% of this population indicates that addressing their vaccination should be a priority.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973709 | PMC |
| http://dx.doi.org/10.3201/eid2903.221231 | DOI Listing |
Publication Analysis
Top Keywords
years age
8
mpox protection
4
protection smallpox
4
smallpox vaccine-generated
4
vaccine-generated antibodies
4
antibodies older
4
older adults
4
adults smallpox
4
smallpox vaccination
4
vaccination confer
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!